Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
about
Mechanisms of Beta Cell Dysfunction Associated With Viral InfectionVirus infections in type 1 diabetesInfection as a cause of type 1 diabetes?The microbiology of human hygiene and its impact on type 1 diabetesThe Crystal Structure of a Coxsackievirus B3-RD Variant and a Refined 9-Angstrom Cryo-Electron Microscopy Reconstruction of the Virus Complexed with Decay-Accelerating Factor (DAF) Provide a New Footprint of DAF on the Virus SurfaceDo viral infections protect from or enhance type 1 diabetes and how can we tell the difference?5'-Terminal deletions occur in coxsackievirus B3 during replication in murine hearts and cardiac myocyte cultures and correlate with encapsidation of negative-strand viral RNA.Beta-cell specific production of IL6 in conjunction with a mainly intracellular but not mainly surface viral protein causes diabetes.Pregnancy loss following coxsackievirus b3 infection in mice during early gestation due to high expression of coxsackievirus-adenovirus receptor (CAR) in uterus and embryoEffect of creatine, creatinine, and creatine ethyl ester on TLR expression in macrophages.Fluoxetine is a potent inhibitor of coxsackievirus replication.The whole genome sequence of coxsackievirus B3 MKP strain leading to myocarditis and its molecular phylogenetic analysis.Reovirus delays diabetes onset but does not prevent insulitis in nonobese diabetic mice.Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection.Viral trigger for type 1 diabetes: pros and consAn aged host promotes the evolution of avirulent coxsackievirus into a virulent strain.Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay.Viral infection of engrafted human islets leads to diabetes.Structure of the 5' nontranslated region of the coxsackievirus b3 genome: Chemical modification and comparative sequence analysis.Injection of the sciatic nerve with TMEV: a new model for peripheral nerve demyelination.Rotavirus infection of infant and young adult nonobese diabetic mice involves extraintestinal spread and delays diabetes onset.Amiloride inhibits the initiation of Coxsackievirus and poliovirus RNA replication by inhibiting VPg uridylylation.Mutational Disruption of cis-Acting Replication Element 2C in Coxsackievirus B3 Leads to 5'-Terminal Genomic Deletions.Replication of coxsackievirus B3 in primary cell cultures generates novel viral genome deletionsRotavirus infection accelerates type 1 diabetes in mice with established insulitisEmergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3.Coxsackievirus infections and NOD mice: relevant models of protection from, and induction of, type 1 diabetes.Helminth infection and type 1 diabetes.Altered immune regulation in type 1 diabetes.Immunoregulatory mechanisms triggered by viral infections protect from type 1 diabetes in miceHistopathology of type 1 diabetes: old paradigms and new insights.Diabetes acceleration or prevention by a coxsackievirus B4 infection: critical requirements for both interleukin-4 and gamma interferon.Protection against or triggering of Type 1 diabetes? Different roles for viral infectionsType 1 diabetes: etiology, immunology, and therapeutic strategies.Group B coxsackieviruses and autoimmunity: focus on Type 1 diabetes.Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma.Prevention or acceleration of type 1 diabetes by viruses.Infection and autoimmune disease.Viral infections and molecular mimicry in type 1 diabetes.
P2860
Q26797519-7B69110D-4FF7-4636-A9CB-A0D0CDBBBC22Q27000117-3B6256A5-8C0C-471C-93B0-228742F6E274Q27026442-F7987FB3-6B73-49B2-98D7-C48DD990EAEDQ27026794-28911F00-77AB-40DF-A0C6-17A0D03406D4Q27673022-2A35A7A3-BFAB-4E7D-A05B-F4A5AFAFFCABQ33577471-FF86929B-69DF-40BA-BE7D-E2753B9A5A7AQ33788804-E0EEBCC2-6738-4363-BE9F-7DCDF1338659Q34084611-CB30B505-829F-4CC9-906D-BD473CF3F5D5Q34163593-CF59DC2F-2E7A-4FA1-AE03-F1C27E5BBB49Q34185252-ADFD9F9D-9CE2-4873-83DC-2E8B270BCB56Q34323429-DBFD1FBA-F888-4743-A512-E19F69B9DCAAQ34405622-DE055F1B-C62D-46C1-9DDE-9E3126644233Q34434860-A7E364F6-4701-426A-A30B-9CCB70849EDEQ34648219-2181EC5D-5542-43BD-96E3-7B80C928D1D4Q34773751-1B9CC0BA-31F3-4B3E-B69D-30CF5434DC2CQ34868678-70E4AC9D-1BE4-4C67-857A-1450D7CC7C3FQ35025154-59CA67C2-E4B1-4FBC-A848-19A2D475DDC6Q35102253-4592F71A-10B7-4526-98FC-25464A9CFF9CQ35220557-7F4E63CF-A649-47F0-BF9C-F92075C6484DQ35634916-E9209B0A-4139-45EC-A93B-EA4136561A2BQ35741728-4F25F236-98A4-433D-9AAD-1F0E00FF537CQ35857180-F7E7B89D-B0C9-4DBB-A4D8-D04F8777CA67Q35972897-D6D53722-7136-4ED9-A6CE-001DC7CA2829Q36281122-811251B2-3A37-4AA5-BCB9-148235CC3E87Q36483302-E4D162FF-212F-489A-9A20-1E285CD1E94DQ36748050-BAF5627A-4E05-454B-8BE0-A84E7114083AQ36755286-AB94624E-D8CC-46A4-BC68-6206CC395111Q36766161-17996514-FE20-4DD0-8089-92A6CD666E17Q37088203-902E0C78-9FA9-4273-95AE-14345E35D953Q37148578-09DA428B-4E34-437C-BCA7-BD8C5017A6B3Q37209245-22A1CD48-76CB-46C9-BBC8-B1525C03705EQ37425106-C645DA49-EABA-45FC-B0DF-AB4B0BC51E45Q37744147-C82F7A1E-C509-44DD-B0B0-5D6D7ED4C5FCQ37821494-73DFA2B1-0CFC-4755-8CFE-E01193DD268BQ37830198-ACA1DBBA-FB49-4B94-B3F8-21FB1121CD77Q37877267-14E0F02D-D813-49D4-80AF-C308C5D4E95BQ37990025-A58BD376-2AA0-486C-86F7-2E07DF48C31BQ38024272-F4A978F6-0585-421A-9D9F-50CF41438D04Q38027432-64D542A2-A926-47A2-ABE6-C508364C2BEDQ38050863-8583515D-8825-4991-B744-8E28E4E6F2E4
P2860
Toward testing the hypothesis that group B coxsackieviruses (CVB) trigger insulin-dependent diabetes: inoculating nonobese diabetic mice with CVB markedly lowers diabetes incidence.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Toward testing the hypothesis ...... dly lowers diabetes incidence.
@ast
Toward testing the hypothesis ...... dly lowers diabetes incidence.
@en
Toward testing the hypothesis that group B coxsackieviruses
@nl
type
label
Toward testing the hypothesis ...... dly lowers diabetes incidence.
@ast
Toward testing the hypothesis ...... dly lowers diabetes incidence.
@en
Toward testing the hypothesis that group B coxsackieviruses
@nl
prefLabel
Toward testing the hypothesis ...... dly lowers diabetes incidence.
@ast
Toward testing the hypothesis ...... dly lowers diabetes incidence.
@en
Toward testing the hypothesis that group B coxsackieviruses
@nl
P2093
P2860
P1433
P1476
Toward testing the hypothesis ...... edly lowers diabetes incidence
@en
P2093
J R Romero
K M Drescher
S Pirruccello
P2860
P304
12097-12111
P356
10.1128/JVI.76.23.12097-12111.2002
P407
P577
2002-12-01T00:00:00Z